Alvotech Expands Assembly and Packaging Capacity with Acquisition of Ivers-Lee Group
Alvotech SA, a global biotech company specializing in biosimilar medicines, has announced the acquisition of Ivers-Lee Group, a family-owned company based in Burgdorf, Switzerland. This acquisition expands Alvotech's capacity in assembly and packaging, integrating Ivers-Lee's operations into its Technical Operations division. Peter Schüpbach, the managing director and grandson of Ivers-Lee's founder, will continue in his role and join Alvotech's senior leadership team. The acquisition supports Alvotech's plans for growth as it prepares to launch three new biosimilars in 2025. Ivers-Lee will remain a separate legal entity but will enhance Alvotech's ability to meet global demand.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alvotech SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW1001117134-en) on July 09, 2025, and is solely responsible for the information contained therein.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。